SmithRx markets itself as a transparent, pass-through PBM: a pricing model that bills plan sponsors the exact amount paid to a pharmacy, returns manufacturer rebates rather than retaining a spread, and charges a flat administrative fee instead of profiting on the difference between what a plan pays and what a pharmacy collects. That pricing philosophy describes how SmithRx bills plan sponsors. It has no bearing on the network participation agreement a pharmacy signs to join the SmithRx network, which is what defines SmithRx's contractual right to audit claims, request documentation, and recoup payment on any claim it finds deficient. An independent pharmacy that receives a PBM audit notice from SmithRx faces the same exposure pharmacies face with any PBM: a documentation deadline, a possible recoupment demand, and a limited window to preserve appeal rights.
A Transparent Pricing Model Is Not an Audit Exemption
SmithRx's public materials describe a network that includes tens of thousands of retail pharmacies nationally, with a stated priority on sustaining independent pharmacies as access points and on working directly with pharmacies to set reimbursement benchmarks. SmithRx also maintains a pharmacy-facing provider manual, a MAC list lookup tool, and a dedicated reimbursement and MAC appeal form, administered through a network operations team a pharmacy can reach directly. None of that infrastructure removes the audit clause inside the participation agreement itself. Every PBM, transparent or otherwise, reserves the contractual right to review claims after adjudication and recover payment on claims that do not match the documentation on file. A pharmacy that treats transparency positioning as a signal of lower audit risk is reading a marketing message into a contract term that says something different.
How a SmithRx Audit Typically Proceeds
Because SmithRx has not published a distinct audit procedure beyond the general framework in its provider manual, the mechanics that apply are the same desk audit and on-site audit process common across the PBM industry. A desk audit begins when a claim, or a pattern across claims, is flagged for review, and the pharmacy receives a written request for supporting records: the original prescription, proof of delivery or a signature log, documentation of copay collection, and sometimes inventory purchase records tied to the dispensed drug. An on-site audit sends a reviewer into the pharmacy to examine the same records in person, often with less advance notice. In both formats, the pharmacy's response window is set by the agreement it signed, and missing that window converts a resolvable documentation gap into a finding the pharmacy never got to contest on the merits. Our companion guide on how to respond to a PBM audit letter walks through that response process in detail, and applies to a SmithRx notice as directly as it does to any other PBM.
Recoupment, Appeal Rights, and Network Status
A finished SmithRx audit that identifies deficient claims typically results in a written notice of recoupment, either as a lump-sum demand or as offsets against future claim payments. Most PBM network agreements, and many state pharmacy audit integrity statutes, give a pharmacy a defined window, commonly 30 days, to file a written audit appeal before recoupment becomes final, though a pharmacy should confirm the exact deadline in its own SmithRx agreement rather than assume a uniform number applies. Repeated or unresolved findings can also expose a pharmacy to network termination, a separate and often larger risk than any single recoupment demand, since it can cut off access to patients covered under that plan. Our guides on Humana pharmacy audits and GLP-1 PBM audits cover the same appeal mechanics and termination exposure, which apply with equal force to a SmithRx audit.
A pricing model built around transparency changes how a PBM bills the plan sponsor. It does not change the audit clause, the documentation deadline, or the recoupment exposure written into the pharmacy's own network agreement.
Why Early Legal Counsel Is Critical
It is critical that pharmacies promptly retain experienced healthcare defense counsel upon receiving a SmithRx audit notice, rather than waiting to see whether the request resolves informally. Early legal intervention can protect the pharmacy's rights, ensure a documentation response is complete and consistent with the underlying network agreement, avoid inadvertent admissions, and preserve appeal rights before a recoupment determination becomes final. Delaying representation can narrow the pharmacy's options and increase the amount ultimately recouped.
How Health Law Alliance Can Help
Health Law Alliance defends independent pharmacies in PBM audits across legacy and newer-entrant plans, including SmithRx. Our bench includes a former federal prosecutor and a former senior pharmacy benefit manager executive, background that shapes how we read a network agreement and structure a response before a documentation deadline runs. If your pharmacy has received a SmithRx audit notice or a recoupment demand, contact us for a free, confidential consultation.
